These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 18469537)

  • 41. Rimonabant abolishes sensitivity to workload changes in a progressive ratio procedure.
    Marusich JA; Wiley JL
    Pharmacol Biochem Behav; 2012 Jun; 101(4):575-80. PubMed ID: 22425597
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Partial agonist-like profile of the cannabinoid receptor antagonist SR141716A in a food-reinforced operant paradigm.
    De Vry J; Jentzsch KR
    Behav Pharmacol; 2004 Feb; 15(1):13-20. PubMed ID: 15075622
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extinction learning of rewards in the rat: is there a role for CB1 receptors?
    Hernandez G; Cheer JF
    Psychopharmacology (Berl); 2011 Sep; 217(2):189-97. PubMed ID: 21519986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats.
    Fattore L; Spano M; Melis V; Fadda P; Fratta W
    Br J Pharmacol; 2011 Aug; 163(7):1550-62. PubMed ID: 21518339
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Second-order schedules of nicotine reinforcement in rats: effect of AM251.
    Wing VC; Shoaib M
    Addict Biol; 2010 Oct; 15(4):393-402. PubMed ID: 20331563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist.
    Gallate JE; Saharov T; Mallet PE; McGregor IS
    Eur J Pharmacol; 1999 Apr; 370(3):233-40. PubMed ID: 10334497
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of am 251, a cannabinoid CB1 receptor antagonist, on food intake in rats.
    Rutkowska M
    Acta Pol Pharm; 2004; 61(5):401-3. PubMed ID: 15747698
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats.
    Sink KS; McLaughlin PJ; Wood JA; Brown C; Fan P; Vemuri VK; Peng Y; Olszewska T; Thakur GA; Makriyannis A; Parker LA; Salamone JD
    Neuropsychopharmacology; 2008 Mar; 33(4):946-55. PubMed ID: 17581535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior.
    Sink KS; Vemuri VK; Olszewska T; Makriyannis A; Salamone JD
    Psychopharmacology (Berl); 2008 Mar; 196(4):565-74. PubMed ID: 18004546
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suppression of feeding, drinking, and locomotion by a putative cannabinoid receptor 'silent antagonist'.
    Gardner A; Mallet PE
    Eur J Pharmacol; 2006 Jan; 530(1-2):103-6. PubMed ID: 16380113
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blockade of CB1 receptors prevents retention of extinction but does not increase low preincubated conditioned fear in the fear incubation procedure.
    Pickens CL; Theberge FR
    Behav Pharmacol; 2014 Feb; 25(1):23-31. PubMed ID: 24346290
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
    Gueye AB; Pryslawsky Y; Trigo JM; Poulia N; Delis F; Antoniou K; Loureiro M; Laviolette SR; Vemuri K; Makriyannis A; Le Foll B
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27493155
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats.
    Fattore L; Spano S; Cossu G; Deiana S; Fadda P; Fratta W
    Neuropharmacology; 2005 Jun; 48(8):1097-104. PubMed ID: 15910886
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Attenuation of cue-induced heroin-seeking behavior by cannabinoid CB1 antagonist infusions into the nucleus accumbens core and prefrontal cortex, but not basolateral amygdala.
    Alvarez-Jaimes L; Polis I; Parsons LH
    Neuropsychopharmacology; 2008 Sep; 33(10):2483-93. PubMed ID: 18059440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ethanol self-administration is regulated by CB1 receptors in the nucleus accumbens and ventral tegmental area in alcohol-preferring AA rats.
    Malinen H; Hyytiä P
    Alcohol Clin Exp Res; 2008 Nov; 32(11):1976-83. PubMed ID: 18782338
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional consequences of the acute administration of the cannabinoid receptor antagonist, SR141716A, in cannabinoid-naive and -tolerant animals: a quantitative 2-[14C]deoxyglucose study.
    Freedland CS; Whitlow CT; Smith HR; Porrino LJ
    Brain Res; 2003 Feb; 962(1-2):169-79. PubMed ID: 12543468
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rimonabant reduces the essential value of food in the genetically obese Zucker rat: an exponential demand analysis.
    Rasmussen EB; Reilly W; Buckley J; Boomhower SR
    Physiol Behav; 2012 Feb; 105(3):734-41. PubMed ID: 22019829
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of CB1 receptor blockade on food-reinforced responding and associated nucleus accumbens neuronal activity in rats.
    Hernandez G; Cheer JF
    J Neurosci; 2012 Aug; 32(33):11467-77. PubMed ID: 22895729
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delta9-THC induced hyperphagia and tolerance assessment: interactions between the CB1 receptor agonist delta9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in rats.
    Järbe TU; DiPatrizio NV
    Behav Pharmacol; 2005 Sep; 16(5-6):373-80. PubMed ID: 16148441
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of cannabinoid receptor antagonists on maintenance and reinstatement of methamphetamine self-administration in rhesus monkeys.
    Schindler CW; Panlilio LV; Gilman JP; Justinova Z; Vemuri VK; Makriyannis A; Goldberg SR
    Eur J Pharmacol; 2010 May; 633(1-3):44-9. PubMed ID: 20153314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.